Evaluation of -[C]PK11195 PET/MRI for Spinal Cord-Related Neuropathic Pain in Patients with Cervical Spinal Disorders

Overview

Journal J Clin Med

Specialty General Medicine

Date 2023 Jan 8

PMID 36614916

Authors

Makoto Kitade

Hideaki Nakajima

Tetsuya Tsujikawa

Sakon Noriki

Tetsuya Mori

Yasushi Kiyono

Hidehiko Okazawa

Akihiko Matsumine

Affiliations

Soon will be listed here.

Abstract

Activated microglia are involved in secondary injury after acute spinal cord injury (SCI) and in development of spinal cord-related neuropathic pain (NeP). The aim of the study was to assess expression of translocator protein 18 kDa (TSPO) as an indicator of microglial activation and to investigate visualization of the dynamics of activated microglia in the injured spinal cord using PET imaging with -[C]PK11195, a specific ligand for TSPO. In SCI chimeric animal models, TSPO was expressed mainly in activated microglia. Accumulation of -[H]PK11195 was confirmed in autoradiography and its dynamics in the injured spinal cord were visualized by -[C]PK11195 PET imaging in the acute phase after SCI. In clinical application of -[C]PK11195 PET/MRI of the cervical spinal cord in patients with NeP related to cervical disorders, uptake was found in cases up to 10 months after injury or surgery. No uptake could be visualized in the injured spinal cord in patients with chronic NeP at more than 1 year after injury or surgery, regardless of the degree of NeP. However, a positive correlation was found between standardized uptake value ratio and the severity of NeP, suggesting the potential of clinical application for objective evaluation of chronic NeP.

Citing Articles

Management of Cervical Spinal Cord Injury without Major Bone Injury in Adults.

Nakajima H, Honjoh K, Watanabe S, Takahashi A, Kubota A, Matsumine A J Clin Med. 2023; 12(21).

PMID: 37959260 PMC: 10650636. DOI: 10.3390/jcm12216795.

HBO treatment enhances motor function and modulates pain development after sciatic nerve injury via protection the mitochondrial function.

Awad-Igbaria Y, Ferreira N, Keadan A, Sakas R, Edelman D, Shamir A J Transl Med. 2023; 21(1):545.

PMID: 37582750 PMC: 10428612. DOI: 10.1186/s12967-023-04414-x.

Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis.

Corasaniti M, Bagetta G, Morrone L, Tonin P, Hamamura K, Hayashi T Int J Mol Sci. 2023; 24(8).

PMID: 37108246 PMC: 10138439. DOI: 10.3390/ijms24087085.

References

Okazawa H, Higashino Y, Tsujikawa T, Arishima H, Mori T, Kiyono Y . Noninvasive method for measurement of cerebral blood flow using O-15 water PET/MRI with ASL correlation. Eur J Radiol. 2018; 105:102-109. DOI: 10.1016/j.ejrad.2018.05.033. View

Honjoh K, Nakajima H, Hirai T, Watanabe S, Matsumine A . Relationship of Inflammatory Cytokines From M1-Type Microglia/Macrophages at the Injured Site and Lumbar Enlargement With Neuropathic Pain After Spinal Cord Injury in the CCL21 Knockout () Mouse. Front Cell Neurosci. 2019; 13:525. PMC: 6881269. DOI: 10.3389/fncel.2019.00525. View

Uchida K, Nakajima H, Okazawa H, Kimura H, Kudo T, Watanabe S . Clinical significance of MRI/(18)F-FDG PET fusion imaging of the spinal cord in patients with cervical compressive myelopathy. Eur J Nucl Med Mol Imaging. 2012; 39(10):1528-37. PMC: 3458200. DOI: 10.1007/s00259-012-2192-y. View

Nakajima H, Uchida K, Takayasu M, Ushida T . A Nationwide Survey of Spinal Cord-Related Pain Syndrome in Japan: Clinical Characteristics and Treatment. Spine Surg Relat Res. 2019; 3(4):319-326. PMC: 6834454. DOI: 10.22603/ssrr.2018-0096. View

Imamoto N, Momosaki S, Fujita M, Omachi S, Yamato H, Kimura M . [11C]PK11195 PET imaging of spinal glial activation after nerve injury in rats. Neuroimage. 2013; 79:121-8. DOI: 10.1016/j.neuroimage.2013.04.039. View

Edison P, Donat C, Sastre M . Imaging of Glial Activation in Alzheimer's Disease. Front Neurol. 2018; 9:625. PMC: 6090997. DOI: 10.3389/fneur.2018.00625. View

Zhang M, Kumata K, Maeda J, Yanamoto K, Hatori A, Okada M . 11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain. J Nucl Med. 2007; 48(11):1853-61. DOI: 10.2967/jnumed.107.043505. View

Barcelon E, Cho W, Jun S, Lee S . Brain Microglial Activation in Chronic Pain-Associated Affective Disorder. Front Neurosci. 2019; 13:213. PMC: 6436078. DOI: 10.3389/fnins.2019.00213. View

Hu X, Liu Y, Wu J, Liu Y, Liu W, Chen J . Inhibition of P2X7R in the amygdala ameliorates symptoms of neuropathic pain after spared nerve injury in rats. Brain Behav Immun. 2020; 88:507-514. DOI: 10.1016/j.bbi.2020.04.030. View

10.

Beggs S, Trang T, Salter M . P2X4R+ microglia drive neuropathic pain. Nat Neurosci. 2012; 15(8):1068-73. PMC: 5023423. DOI: 10.1038/nn.3155. View

11.

Nakajima H, Watanabe S, Honjoh K, Kubota A, Matsumine A . Symptom-based pharmacotherapy for neuropathic pain related to spinal disorders: results from a patient-based assessment. Sci Rep. 2022; 12(1):7192. PMC: 9064937. DOI: 10.1038/s41598-022-11345-y. View

12.

Lang S . The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology. Curr Med Chem. 2002; 9(15):1411-5. DOI: 10.2174/0929867023369745. View

13.

Jeon S, Seo S, Lee J, Choi S, Lee D, Jung Y . [11C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome: A pilot study. Medicine (Baltimore). 2017; 96(1):e5735. PMC: 5228673. DOI: 10.1097/MD.0000000000005735. View

14.

Yasin N, Veenman L, Singh S, Azrad M, Bode J, Vainshtein A . Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling. Int J Mol Sci. 2017; 18(4). PMC: 5412370. DOI: 10.3390/ijms18040786. View

15.

Woolf C, Mannion R . Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999; 353(9168):1959-64. DOI: 10.1016/S0140-6736(99)01307-0. View

16.

Viviano M, Barresi E, Simeon F, Costa B, Taliani S, Da Settimo F . Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging. Curr Med Chem. 2022; 29(28):4862-4890. PMC: 10080361. DOI: 10.2174/0929867329666220329204054. View

17.

Popovich P, Guan Z, McGaughy V, Fisher L, Hickey W, Basso D . The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation. J Neuropathol Exp Neurol. 2002; 61(7):623-33. DOI: 10.1093/jnen/61.7.623. View

18.

Okazawa H, Ikawa M, Jung M, Maruyama R, Tsujikawa T, Mori T . Multimodal analysis using [C]PiB-PET/MRI for functional evaluation of patients with Alzheimer's disease. EJNMMI Res. 2020; 10(1):30. PMC: 7105527. DOI: 10.1186/s13550-020-00619-z. View

19.

Schuitemaker A, Kropholler M, Boellaard R, van der Flier W, Kloet R, van der Doef T . Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study. Neurobiol Aging. 2012; 34(1):128-36. DOI: 10.1016/j.neurobiolaging.2012.04.021. View

20.

Tsuda M . Microglia in the spinal cord and neuropathic pain. J Diabetes Investig. 2016; 7(1):17-26. PMC: 4718109. DOI: 10.1111/jdi.12379. View